Page last updated: 2024-09-05

cholecystokinin 9 and Osteosarcoma

cholecystokinin 9 has been researched along with Osteosarcoma in 1 studies

*Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, F; Dong, Z; Guo, Y; Li, Y; Lu, J; Xiao, Y1

Other Studies

1 other study(ies) available for cholecystokinin 9 and Osteosarcoma

ArticleYear
Ginsenoside Rg3 Suppresses Proliferation and Induces Apoptosis in Human Osteosarcoma.
    BioMed research international, 2018, Volume: 2018

    Topics: Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cholecystokinin; Ginsenosides; Humans; Osteosarcoma; Peptide Fragments; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases

2018